Calprotectin in viral systemic infections—COVID-19 versus hepatitis C virus

This study aims to evaluate differences in serum and fecal calprotectin in patients with HCV chronic hepatitis and COVID-19 infection and compare them to a control group. This observational study was performed between April 2020 and October 2020 in a single Internal Medicine center. We determined se...

Descripción completa

Detalles Bibliográficos
Autores principales: Toma, Letitia, Dodot, Mihai, Zgura, Anca, Bacalbasa, Nicolae, Silaghi, Andrei, Simu, Razvan, Isac, Teodora, Mercan-Stanciu, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274470/
https://www.ncbi.nlm.nih.gov/pubmed/34254197
http://dx.doi.org/10.1007/s10238-021-00743-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274470/
https://www.ncbi.nlm.nih.gov/pubmed/34254197
http://dx.doi.org/10.1007/s10238-021-00743-7

Ejemplares similares